OAANX
Price
$14.08
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
PAAQX
Price
$14.20
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

OAANX vs PAAQX

Header iconOAANX vs PAAQX Comparison
Open Charts OAANX vs PAAQXBanner chart's image
Invesco Active Allocation R
Price$14.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Invesco Active Allocation R6
Price$14.20
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
OAANX vs PAAQX Comparison Chart
Loading...
VS
OAANX vs. PAAQX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OAANX is a StrongBuy and PAAQX is a Sell.

FUNDAMENTALS
Fundamentals
OAANX (1.95B) and PAAQX (1.95B) have equal amount of cash in the bank . PAAQX pays higher dividends than OAANX: PAAQX (1.92) vs OAANX (1.40). OAANX was incepted earlier than PAAQX: OAANX (19 years) vs PAAQX (5 years). OAANX (21.00) and PAAQX (21.00) have comparable annual turnover. OAANX has a lower initial minimum investment than PAAQX: OAANX (1000) vs PAAQX (1000000). PAAQX (14.74) and OAANX (14.13) have marching annual gain over last year. PAAQX return over 5 years is better than : 5.03 vs. OAANX (2.16).
OAANXPAAQXOAANX / PAAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years5 years-
Gain YTD8.3918.81295%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.95B1.95B100%
Annual Yield % from dividends1.401.9273%
Returns for 1 year14.1314.7496%
Returns for 3 years-9.90-8.39118%
Returns for 5 years2.165.0343%
Returns for 10 years27.30N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLAB126.153.35
+2.73%
Mesa Laboratories
GL106.650.47
+0.44%
Globe Life
XFOR0.70N/A
+0.06%
X4 Pharmaceuticals
WAFD36.07-0.26
-0.72%
WaFd
GTBP2.18-0.07
-3.11%
GT Biopharma